1. Choonara, I. (2000) Clinical trials of medicines in children: US experience shows how to ensure that treatment of children is evidence based. Br. Med. J.
321, 1093–1094.
2. Conroy, S., McIntyre, J., and Choonara, I. (1999) Unlicensed and off label drug use in neonates. Arch. Dis. Child.
80, F142–F145.
3. Conroy, S., Choonara, I., Impicciatore, P., Mohn, A., Arnell, H., Rane, A., Knoeppel, C., Seyberth, H., Pandolfini, C., Raffaelli, M.P., Rocchi, F., Bonati, M., ‘t Jong, G., de Hoog, M., and van den Anker, J. (2000) Survey of unlicensed and off label drug use in pediatric wards in European countries. Br. Med. J.
320, 79–82.
4. Committee on Drugs, American Academy of Pediatrics. (1995) Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations. Pediatrics
95(2), 286–294.
5. WHO (1986) Principles for evaluating health risks from chemicals during infancy and early childhood: the need for a special approach. International Programme on Chemical Safety. Environmental Health Criteria 59. World Health Organization, Geneva.